Serum Institute of India seeks DCGI permission for phase 2/3 clinical trials of Oxford’s COVID-19 vaccine

The Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials of ‘Covidshield’, according to sources